The results prompted us to conduct a preliminary functional analysis to investigate the effect of specifically inhibiting or overexpressing claudin-4 in aggressive and non-aggressive breast cancer cells, respectively, on VM. The gene discussed is CLDN4; the disease is breast cancer.